7 cardiology startups you need to know

Clockwise from top left: Safebeat Rx’s AFib remote monitoring, LiveMetric wearable blood pressure monitor, Respirix’s Cardiospire noninvasive hemodynamic monitor, CardiaCare wearable noninvasive nerve stimulator {images courtesy of the companies]

In the fast-evolving field of cardiology, medical device startups are emerging as key players, bringing new ideas and technologies to the table.

With a focus on agility and creativity, cardiology medical device startups are challenging established players in the industry and disrupting traditional models of healthcare delivery. From wearables and remote monitoring devices to AI-powered diagnostics and minimally invasive procedures, these startups are redefining what is possible in the world of cardiology.

Investors are taking notice of the potential of these startups, pouring millions of dollars into their ventures. As a result, many of these companies are experiencing rapid growth and expanding their reach across the globe.

As the cardiology landscape continues to evolve, medical device startups are likely to play an increasingly important role in shaping the future of the industry. These seven companies are developing innovative solutions that aim to improve the diagnosis, treatment and management of cardiovascular diseases.

The seven startups below (and 15 others) will showcase their technology as a part of MedTech Innovator’s accelerator program pitches at DeviceTalks Boston on May 10-11.

CardiaCare's AFib home monitoring device [Image courtesy of CardiaCare]

LiveMetric's wearable blood pressure monitor [Image courtesy of LiveMetric]

MeaCor's cryoadhesion device for mitral and tricuspid valves [Image courtesy of MeaCor]

Respirix's Cardiospire noninvasive hemodynamic monitoring

SafeBeat Rx's remote monitoring for AFib [Image courtesy of SafeBeat]

CardiaCare: Closed-loop wearable for noninvasive treatment of cardiac clinical symptoms

Rehovot, Israel
Founded: 2015

CardiaCare is a clinical-stage digital therapeutic company that is developing a closed-loop wearable device for the noninvasive treatment of cardiac and other central nervous system-related clinical symptoms. The nerve stimulation system has continuous monitoring and AI-based alert capabilities to enable complete remote patient management and personalized treatment.

The company currently has a functional prototype and has successfully completed a first-in-man study. CardiaCare is also a 2022 MedTech Innovator cohort company.

Check out CardiaCare’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Corveus Medical: Pressure relief therapy for heart failure

Houston
Founded: 2021

Corveus Medical is developing pressure-relief therapy for heart failure patients through a targeted, minimally invasive nerve ablation procedure. The company designed the catheter-based device to safely perform nerve ablation in the upper abdomen. It targets a specific area to reduce collateral tissue damage.

Check out Corveus Medical’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

LiveMetric: Continuous blood pressure wearable

Luxembourg
Founded: 2016

LiveMetric is the only FDA-cleared, calibration-free, cuff-free, continuous blood pressure wearable that provides thousands of measurements per month. The measurements are digitally transmitted to a provider to help make important care and treatment decisions. The company’s LiveOne device uses algorithms that analyze a person’s radial artery pressure to produce diastolic, systolic and pulse rates for people ages 27 and up.

Check out LiveMetric’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

MeaCor: Cryoadhesion to treat mitral and tricuspid valves

Montreal, Quebec
Founded: 2015

MeaCor is developing an anchoring catheter that uses on-demand cryoadhesion for the treatment of mitral and tricuspid valves. The cryoadhesion system compensates for heart motion and mimics the current surgical annuloplasty standard of care. It has a 15 Fr catheter, steerable tip and two pre-loaded anchors that can mimic suture strength.

Check out MeaCor’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Monarch Bio: Aneurysm occluder

Los Angeles
Founded: 2011

Monarch Bio has developed its Titan Flow Diverter that leverages thin film nitinol (TFN) technology to achieve faster and more reliable aneurysm occlusion. The technology uses an omni-direction thin film mesh to cover a neurovascular support stent to restrict blood flow into the aneurysm, which can cause the aneurysm to stagnate and acts as a scaffold for rapid re-endothelization of the vessel wall.

Check out Monarch Bio’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Respirix: Cardiospire noninvasive hemodynamic monitoring

San Francisco
Founded: 2015

Respirix’s Cardiospire technology is a new approach to noninvasive hemodynamic monitoring using airway pressure for continuous, high-fidelity modeling of stroke volume and pulmonary artery pressures. Cardiospire is placed inline using a capnography adapter and provides accurate AI modeling of core hemodynamic parameters. It displaces the catheterization risk and removes the guesswork from hemodynamic management to improve patient outcomes.

Check out Respirix’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Safebeat Rx: Cardiac implantable electronic device monitoring

St. Louis, Missouri
Founded: 2020

SafeBeat has developed technology that expands access to remote patient monitoring, continuous telemetry and event monitoring. It also has software-enabled remote therapeutic monitoring and cardiac implantable electronic device monitoring powered by automated artificial intelligence-based software. According to the company, the system has ECG interpretation and treatment management coupled with AI to increase physician efficiency with automated insights.